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Abstract Continuous-flow left ventricular assist devices
(CF-LVADs) generally operate at a constant speed, which
reduces pulsatility in the arteries and may lead to compli-
cations such as functional changes in the vascular system,
gastrointestinal bleeding, or both. The purpose of this study
is to increase the arterial pulse pressure and pulsatility by
controlling the CF-LVAD flow rate. A MicroMed DeBakey
pump was used as the CF-LVAD. A model simulating the
flow rate through the aortic valve was used as a reference
model to drive the pump. A mock circulation containing
two synchronized servomotor-operated piston pumps act-
ing as left and right ventricles was used as a circulatory
system. Proportional-integral control was used as the con-
trol method. First, the CF-LVAD was operated at a con-
stant speed. With pulsatile-speed CF-LVAD assistance, the
pump was driven such that the same mean pump output
was generated. Continuous and pulsatile-speed CF-LVAD
assistance provided the same mean arterial pressure and
flow rate, while the index of pulsatility increased signifi-
cantly for both arterial pressure and pump flow rate signals
under pulsatile speed pump support. This study shows the
possibility of improving the pulsatility of CF-LVAD sup-
port by regulating pump speed over a cardiac cycle without
reducing the overall level of support.
Keywords Continuous-flow left ventricular assist device
(CF-LVAD)  Arterial pulsatility  In vitro experiment
1 Introduction
Continuous-flow left ventricular assist devices (CF-
LVADs) generally operate at a constant speed. However,
constant-speed CF-LVAD assistance reduces the pulse
pressure and index of pulsatility over a cardiac cycle,
which may lead to long-term complications [1]. Patients
under pulsatile support exhibit less remodeling and func-
tional changes in their vascular system compared to those
of patients under constant-flow support [2–9]. This leads to
less gastrointestinal (GI) bleeding, aortic wall remodeling,
and better vascular auto-regulatory function. Geisen et al.
reported that non-surgical bleeding in CF-LVAD patients
can be explained by acquired von Willebrand disease [10].
However, Crow et al. reported that loss of von Willebrand
factor multimeres alone cannot be a predictor of GI
bleeding [11]. Nevertheless, comparative studies showed
that loss of von Willebrand factor is higher under CF-
LVAD support than under pulsatile assist device support
[12, 13], which may be interpreted as pulsatile circulatory
support being more beneficial for CF-LVAD patients.
Under pulsatile support, pulmonary vascular resistance
reduces more than it does under constant flow support [14].
Furthermore, long-term organ function appears to be pre-
served better with pulsatile support [15–17]. Inflammatory
responses reportedly occur at a lower rate in patients under
pulsatile support as well [18, 19].
Comparison results of pulsatile vs. continuous flow
cardiac support and the benefits of pulsatile perfusion have
been summarized in the literature [20–22]. From these
studies, it is clear that pulsatile support may be beneficial
for reducing the late complications of CF-LVAD support.
Furthermore, solutions have been proposed to increase
arterial pulsatility. For instance, Shiose et al. [23] proposed
a speed modulation algorithm for a continuous-flow total
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artificial heart to generate physiologic arterial waveforms.
They generated three speed profiles, namely sinusoidal,
rectangular, and optimized (physiological) speed profiles,
and assessed them using a mock circulatory system. Arte-
rial pulse pressure was highest under the rectangular speed
profile of CF-LVAD. A stepwise CF-LVAD operating
speed change over a cardiac cycle was proposed to increase
arterial pulsatility [24] by changing the pump speed from a
low value to a high value at the peak systole to keep the
arterial pressure increasing despite the start of left ventricle
relaxation. CF-LVAD operating speed was reduced to a
low value again at the end of the systole to reduce the CF-
LVAD output at the diastolic phase. Although such a CF-
LVAD driving mode increases arterial pulsatility, its
implementation was not considered in this particular study.
A similar method for adjusting CF-LVAD operating speed
at high and low levels over a cardiac cycle has been pro-
posed [25]. Unlike the preceding application, the high CF-
LVAD operating speed was applied over the entire systolic
phase in this study. A method for synchronizing the CF-
LVAD speed and systolic phase has been proposed [26]. A
pacing lead was used to detect the ventricular electrocar-
diogram for the synchronization of the RBP speed change.
The energy equivalent pressure was 9 % higher than the
mean aortic pressure under pulsatile-speed CF-LVAD
support when the CF-LVAD was operated in co-pulsative
mode, whereas these two parameters were almost at the
same level under constant-speed CF-LVAD support. Shi
et al. [27, 28] evaluated the cardiovascular response under
pulsatile CF-LVAD support using a numerical model by
applying various pulsation ratios and phase shift values to
the RBP motion profile. An optimization algorithm for
balancing the importance of the characteristic cardiovas-
cular variables by introducing a cost function was used. In
these studies, the operating speed of the CF-LVAD was
changed directly. Although this increases the arterial pul-
satility, it may not generate physiological pressure and flow
signals in the arteries. Using CF-LVAD flow rate signals
rather than direct speed control would generate more
physiological blood flow in the arteries. Such an applica-
tion was presented [29, 30] by using various CF-LVAD
flow rate signal profiles to modulate the operating speed in
order to increase pulsatility. The pulse width and amplitude
of the flow signal through the pump was changed to assess
the effects of the CF-LVAD flow profiles. Although the
possibility of increasing pulsatility through pump control
was shown, the control method itself was not considered in
the numerical simulations. Therefore, this study was
unclear in terms of control system design and whether such
an operation mode for CF-LVAD is achievable for flow
rate signals with relatively high amplitude.
The present study aims to operate a CF-LVAD in co-
pulsation support mode, similar to previous studies
[31, 32], and assess whether the co-pulsation support mode
significantly increases arterial pulsatility in a mock circu-
latory system. Furthermore, a complete control method is
presented and applied experimentally by using a physio-
logical model to describe the reference pump flow. Flow
rate was used as a control variable instead of pump oper-
ating speed, unlike in other studies.
2 Materials and Methods
The mock circulatory system, shown in Fig. 1, contained
two synchronized servomotor-operated piston pumps act-
ing as the left and right ventricles, respectively. The ven-
tricles were connected to the circulation system via two
polyurethane valves. The systemic circulation was modeled
by a cylindrical, polyurethane tube with a constant diam-
eter of 25 mm. The systemic and pulmonary impedance
were modeled by four-element Windkessel models, posi-
tioned distal from the aorta and pulmonary valve, respec-
tively. Compliance chambers represented passive atria and
functioned as a preload for ventricular filling. Further
information about this system can be found elsewhere [33].
A numerical model describing the left atrial, left ven-
tricular, and systemic arterial dynamics was used for
deriving the reference flow rate over a cardiac cycle in the
control application. The ventricle model is based on the
model developed by Bovendeerd et al. [34]. This model
describes the ventricular wall mechanics using myocardial
constitutive properties. The ventricular wall mechanics
model relates the macroscopic ventricular pressure and
volume to microscopic tissue properties, namely fiber
stress, fiber strain, radial wall stress, and radial wall strain.
Active and passive fiber stress relations include the
myocardial constitutive laws for fiber stress and radial
stress. Detailed information about the full heart model can
be found elsewhere [34]. The circulatory system is
described with a lumped parameter model including elec-
trical analogues for resistance and compliance [35]. Simi-
larly, the heart valves were modeled as ideal diodes,
allowing one-way blood flow. The left atrium was modeled
as a passive compliance only.
To regulate the CF-LVAD operating speed, straight-
forward proportional-integral (PI) control was applied as
the control method. The control application includes three
main components, namely a PI controller, a DC motor
driver, and the CF-LVAD. A PI controller is defined as:
u tð Þ ¼ Kp  e tð Þ þ Ki
Z t
0
e hð Þdh ð1Þ
In a PI control application, proportional gain (Kp) is
multiplied by the control error e(t) to reduce the instant
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difference between the reference CF-LVAD flow rate and
actual CF-LVAD flow rate. Integral gain (Ki) is multiplied
by the integration of the control error over time. The sum
of both actions (P and I) constitutes the output of the
controller, u(t), which is the input voltage (Vin) of the DC
motor driver in this application. The output of the DC
motor driver (Vout) was the input of the CF-LVAD motor,
which drives the impeller in the heart pump. A schematic
representation of the mock circulation and the block dia-
gram of the control application are given in Fig. 2.
The control algorithm was developed using Matlab
Simulink R2006a and employed a Runge–Kutta solver
scheme. The time stepwas 0.001 s. To enable pulsatile pump
speed control, an industrial brushless DC motor driver was
used (Maxon DECS 50/5, Maxon, Switzerland) for driving
the CF-LVAD. This driver uses an input voltage as the ref-
erence signal to regulate the pump operating speed towards a
certain level. The maximum signal input voltage of this
driver is 5 V [36]. A MicroMed DeBakey CF-LVAD was
used as the assist device. Compared to other devices, this
device ismore responsive to the control input signals over the
duration of a cardiac cycle. Additionally, it has a flow sensor
attached, enabling direct feedback of the control variable. In
the control application, the peak of the CF-LVAD flow was
applied at peak systole tomaximize the peak arterial pressure
and arterial pulse pressure. However, this device cannot
respond fast enough to the control input signals. Therefore,
there is a delay between the reference CF-LVAD flow and
actual CF-LVAD flow. The duration of this delay (D) is the
time elapsed between the peak of the reference CF-LVAD
flow and the peak of the actual CF-LVAD flow (Fig. 5).
Therefore, the peak of the reference CF-LVAD flow signal
should be applied before the peak systole, considering the
duration of this delay (D), to apply the peak of the actual CF-
LVAD flow at the peak systole. The reference CF-LVAD
flow rate signal was shifted to the left on the time axis by
using a delay block from theMatlab Simulink library (Fig. 2)
in the control algorithm. Furthermore, the mock circulatory
system is controlled by using Matlab Simulink R2006a. It
was thus possible to acquire the pressure, flow data, and time
over a cardiac cycle and synchronize the control signals with
the mock circulatory system.
In the experiments, left ventricular and aortic pressures
were monitored using pressure sensors (Becton–Dickinson
Fig. 1 Mock circulation system
used in experiments
Fig. 2 Schematic representation of mock circulation (top view) and
block diagram of control application. Q and p are flow rate and
pressure, LV and RV represent the left and right ventricles, R and
C denote resistance and compliance, respectively. MV, AV, TV, and
PV are mitral, aortic, tricuspid, and pulmonary valves, and ao, lv, and
la are aorta, left ventricle, and left atrium, respectively. m is model,
ref is reference, and e, Vin, and Vout are error and input and output
voltages of DC motor driver in the control application, respectively.
D is applied delay to synchronize CF-LVAD flow rate, and 1, 2, 3,
and 4 denote resistances in afterload sections
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Medical P10EZ-1). The CF-LVAD flow rate was measured
with a Transonic ME13PXN flow probe at the outlet of the
pump, connected to a Transonic 410 flow meter (Tran-
sonic, Ithaca, NY).
The pulsatility was quantified using the index of pul-
satility (Ip) [37] defined as:
Ip ¼ Xmax  Xminð Þ=Xmean ð2Þ
where X denotes the hemodynamic variable that is con-
sidered in the calculation of the index of pulsatility.
For comparison, the CF-LVAD was operated at a con-
stant speed, generating the same mean pump output as that
obtained in pulsatile pump speed control mode.
The data obtained from the experiments were analyzed
using one tailed t test in Microsoft Excel 2007. A p value of
less than 0.05 was considered to be significant.
First, the experiments were performed under healthy and
pathological conditions. The contractility of the left ven-
tricular model in themock circulatory systemwas reduced in
order to obtain the dilated cardiomyopathy (DCM) condi-
tions. A total of ten experiments were performed for the
assisted circulatory system with constant- and pulsatile-
speed CF-LVAD assistance. The heart rate was kept at
75 bpm during the experiments. The systemic arterial
resistance was adjusted manually to obtain physiological
pressure and flow signals in the systemic arteries. Contrac-
tility values that represented mild (c = 0.8) and severe
(c = 0.5) heart failure were used to assess the pump per-
formance and improvement in pulsatility under pulsatile-
speed CF-LVAD support. The settings applied in the
experiments for the assisted circulation are given in Table 1.
3 Results
Representative left ventricular and aortic pressure signals
and the flow rate signal through the aortic valve for healthy
and DCM conditions are given in Fig. 3.
The results are given for the CF-LVAD-assisted failing
heart under various assistance modes for a given mean
pump output (3.6 L/min). The aortic pressure and pump
flow rate under pulsatile- and constant-speed CF-LVAD
assistance modes are given in Fig. 4a, b, respectively. The
CF-LVAD input voltage and operating speed for the pul-
satile-speed pump support mode are given in Fig. 4c, d,
respectively.
Under pulsatile-speed CF-LVAD assistance mode, the
amplitudes of the aortic pressure signals are larger than those
obtained with constant-speed CF-LVAD assistance. Under
both operation modes, the mean aortic pressure was
86 mmHg. Under pulsatile-speed CF-LVAD support, the
amplitude of the measured pump flow signals was higher
than that of the flow signal with constant-speed CF-LVAD
support. Themean flow ratewas 3.6 L/min for both operation
modes. A sudden increase in the CF-LVAD input voltage
was observed due to the applied reference pump flow in the
systolic phase. The input voltage saturated at 5 V because of
the DC motor driver limits. A rapid decrease followed the
saturation with the relaxation of the ventricle and the input
voltage decreased to a minimum. The input voltage
increased again in the diastolic phase to avoid regurgitant
CF-LVAD flow due to a relatively high afterload. The CF-
LVAD operating speed shows a similar change over a car-
diac cycle. It increased to a maximum level at around
12.5 k rpm in the systolic phase and decreased to around
8.5 k rpm with the relaxation of the left ventricle. It
increased in the diastolic phase due to a high afterload to
avoid reverse flow through the pump. The reference and
measured CF-LVAD flow rates are given in Fig. 5.
There was a delay (D) between the reference and mea-
sured CF-LVAD flow signals in pulsatile-speed operation
mode. Although the CF-LVAD input voltage and operating
speed increased in the diastolic phase as well as the systolic
phase, there was no significant increase in the CF-LVAD
flow because of the high afterload. Therefore, increases in
the input voltage and operating speed of the CF-LVAD
slightly affected the pump flow.
Figure 6 shows a comparison of the hemodynamic
variables under assistance with various operation modes.
Under constant-speed CF-LVAD assistance, the aortic
pulse pressure was lower than that under pulsatile-speed
CF-LVAD operation mode (p\ 0.05). For the two opera-
tion modes, the mean aortic pressure was at the same level
(p[ 0.05). Similar to the aortic pulse pressure, the index of
pulsatility in the aortic pressure was significantly higher
under pulsatile-speed CF-LVAD support (p\ 0.05). Also,
the generated CF-LVAD flow rate was the same in both
support modes (p[ 0.05), while the amplitudes of the CF-
LVAD flow rate and index of pulsatility were both sig-
nificantly higher under pulsatile-speed CF-LVAD support
(p\ 0.05).
Table 1 Applied settings in experiments for assisted circulation
Contractility Reference CF-LVAD
flow rate (L/min)
1 0.5 2.6
2 0.5 3.1
3 0.5 3.6
4 0.5 4.1
5 0.5 4.6
6 0.8 2.5
7 0.8 3.0
8 0.8 3.9
9 0.8 4.5
10 0.8 5.0
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4 Discussion
The aim of this study was to show the possibilities of
pulsatile CF-LVAD assistance compared to constant-speed
support in a mock circulatory system. The operating speed
of a MicroMed DeBakey CF-LVAD was regulated by
applying PI control to the pump flow rate to increase
arterial pulsatility. The proposed control strategy increased
the pulse pressure and Ip in the arterial pressure signals
over a cardiac cycle without reducing the level of support.
Fig. 3 Experimental results for healthy (h) and DCM (dcm) conditions. a plv,h and pao,h are pressures in left ventricle and aorta, respectively, for
healthy settings, b Qav,h is flow rate through aortic valve for healthy settings, c plv,DCM and pao,DCM are pressures in left ventricle and aorta,
respectively, for DCM settings, and d Qav,DCM is flow rate through aortic valve for DCM settings
Fig. 4 a Aortic pressures (pao) under pulsatile- (ps) and constant-speed (cs) CF-LVAD operation modes, b pump flow rates (Qcf-lvad) under
pulsatile- (ps) and constant-speed (cs) CF-LVAD operation modes, c DC motor driver system input voltage (Vin), and d CF-LVAD operating
speed (xCF_LVAD)
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The applied control strategy was used to increase the pump
flow at the systolic phase and to minimize flow in the
diastolic phase. This strategy increased the arterial pul-
satility index by regulating the pump operating speed.
However, a change in arterial pulsatility depends on several
factors, such as the preload and afterload of the left ven-
tricle and the pressure-flow relation at different speeds of
the CF-LVAD. With a change in the preload and afterload,
the pulsatility index increases due to synchronization of the
pump and the heart. The level of increase is determined by
the pressure-flow characteristics of the CF-LVAD.
The flow rate through the CF-LVAD did not strictly
follow the reference model due to the design of the pump.
The main mechanical components of the CF-LVAD are the
inducer, the impeller, and the diffuser. The main electrical
components are the stator and rotor, which also functions
as the impeller. It is thought that because of the gap
between the embedded magnets in the impeller and the coil
in the stator, the pump response is not sufficiently fast to
follow the reference. Moreover, the DC motor allows a 5-V
maximum input voltage to drive the pump. Using feedback
control increased arterial pulsatility (Fig. 4a). The flow
sensor Micromed CF-LVAD allows the flow rate through
the pump to be measured, which makes the operation mode
reliable even during long-term use. Although the instan-
taneous tracking error was considerable in the pulsatile-
speed CF-LVAD support mode, the control algorithm
doubled the amplitude and pulsatility index in arterial
pressure and the CF-LVAD flow rate signals. Due to the
construction of CF-LVADs, fast changes of pump speed
are difficult to achieve. Adding a more aggressive pump
speed control may be convenient to increase the benefit of
the applied control strategy. This, however, will lead to
higher power consumption, which, in view of the battery
power current CF-LVADs rely on, may be difficult to
achieve.
The strength of the contractions in the heart is an
important parameter affecting the pulsatility in the arteries.
The heart becomes more dominant for the higher contrac-
tility values. Therefore, the pulsatile-speed CF-LVAD
generates less pulsatility in comparison to lower contrac-
tility values. Nevertheless, speed variations in both heart
failure modes increase arterial pulsatility.
It has been shown that co-pulsative CF-LVAD support
increases arterial pulsatility in animal experiments and
isolated beating heart experiments [26, 32]. However,
direct rotation speed control does not yield physiological
shapes in the arterial pressure and flow signals [26]. An
approach [32] that applies flow rate control to regulate the
CF-LVAD operating speed accordingly over a cardiac
cycle has been presented. In that study the applied refer-
ence model was able to generate physiological pressure and
flow signals and increase arterial pulsatility and it was
described by a few parameters. In this application, the
parameters can be adjusted to generate a reference model
for the changing conditions in a patient.
Synchronization of the CF-LVAD speed is important to
achieve such an operation mode in patients. Most CF-
LVAD patients have an implantable cardioverter defibril-
lator along with a CF-LVAD [38]. In these patients, syn-
chronization of the CF-LVAD can be done according to the
cardioverter defibrillator signals. Also, natural ECG has a
very sharp peak (the R-peak in the QRS-complex) at the
beginning of the heart cycle. This peak is widely used for
synchronization purposes clinically, e.g., in imaging
methods such as magnetic resonance imaging or computed
tomography. Synchronizing a pump with this signal should
not be difficult. Ando et al. presented such an example in
their study [26].
Fig. 5 Reference CF-LVAD flow rate (Qref) and actual CF-LVAD
flow rate (QCF-LVAD) (D represents applied delay synchronizing CF-
LVAD flow rate)
Fig. 6 a Arterial pulse pressure, b mean aortic pressure, c index of
pulsatility in aortic pressure, d amplitude of CF-LVAD flow rate,
e mean pump output, and f index of pulsatility in pump flow rate
under constant- (CS) and pulsatile-speed (PS) CF-LVAD support
(error bars represent 29 standard deviation)
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5 Conclusion
Numerous studies have reported the beneficial effects of
pulsatile mechanical circulatory support over continuous-
speed support. This study showed and quantified the effects
of pulsatile operating speed over a cardiac cycle to improve
arterial pulsatility. Statistical analysis showed that there is
a significant increase in arterial pulsatility under co-pul-
sative CF-LVAD support mode.
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